RE: Off topic..FUM, but is it ?5 Apr 2023 21:05
evening bignose.been out all day with one of my grandchildren at a tennis tournament,so missed the reaction to the fum results. no nasty surprises and good news on the cash runway, although its length is going to be dictated by forthcoming revenue etc,so we will have to see how it goes.as you say,a significant upfront payment on FDA licence would change the scenario significantly,but my personal expectations there are conservative,probably as a result of hyper- cynicism generated by prolonged exposure to regent. i am hoping we will hear the result before the end of May.doubt we will get any reliable information about sales for 6 months plus,although we my get some anecdotal comments in the interim.fum were quick off the mark with the patent application(dec2019 i think) so hopefully news within the next 9 months or so. I've given up speculating on regent's failures in this and other respects.bit of a fatalist attitude now im afraid. on the manufacturing front,i'm hopeful that the relatively simple nature of med30000 (no active ingredients and no two drug combination issues which seen to have bedevilled fortacin) will mean what we don't face real issues in this regard. if supply problems arise from excessive demand then i would probably be quite pleased. im not expecting any significant increase in s/p until FDA news,as i think people are more inclined to derisk in advance of results rather than increase their holding,but at this point i think fum represents an excellent risk v reward prospect. hope i'm right.